Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIAB-PHC1 vs Metformin in Type 2 Diabetes
NCT07279909Phase 3Active, not recruiting
- Sponsor
- Hamdard University
- Start
- Mar 2024
- Primary completion
- Aug 2025
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DIAB-PHC1 in type 2 diabetes mellitus (T2DM), sponsored by Hamdard University. Started Mar 2024; status: active, not recruiting.
02
Drugs
DIAB-PHC1
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07279909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07279909.